transplantation

3:47
An eHealth-powered integrated nurse-led model of care post-transplant
Lynn Leppla
2:23
Sorafenib for FLT3-ITD-positive AML
Andreas Burchert
2:09
Management & resarch for CTCL at the City of Hope
Steven Rosen
1:41
Applying the right therapies to the right AML patient population
Christoph Röllig
1:28
The role of Cure Leukemia in improving access to clinical trials for patients
Charles Craddock
2:27
What are the challenges of integrating therapy around autologous transplantation?
John Kuruvilla
1:57
Promising new combinations in the treatment of myeloma
Evangelos Terpos
2:50
Current standard of care for patients who are eligible for autologous stem cell transplantation
Michele Cavo
4:59
Conflicting results of the EMN02 and staMINA trials
Michele Cavo
1:03
What is induction therapy for autologous stem cell transplanation?
Michele Cavo
T-cell lymphoma: autologous or allogeneic transplant?
Francine Foss
1:48
Managing problems in treating CLL
Anna Schuh
1:18
Treatment options for leukemia patients who fail the standard of care
Paolo Ghia
1:13
Have novel drugs made stem cell transplantation obsolete?
David Maloney
3:51
Celebrating 60 years of successful allogeneic transplant at EHA 2017
Mohamad Mohty
5:22
Lymphoid Highlights from BSH 2017
George Follows
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals